Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Mouse Cnrip1 ELISA Kit (AC2570)
Cat.#: ASET-1159
Specifications
Description Mouse Cnrip1 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of mouse Cnrip1 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Mouse Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 9.93 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 125-2000 ng/mL Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2008 Human DIO2 ELISA Kit (AC3419) Quantitative inquiry ASET-1872 Human 5HT1A Receptor ELISA Kit (AC3283) Quantitative inquiry ASET-1743 Human TMPRSS2 ELISA Kit (AC3154) Quantitative inquiry ASET-1041 Mouse CORT ELISA Kit (AC2452) Quantitative inquiry ASET-1867 Human Visfatin ELISA Kit (AC3278) Quantitative inquiry ASET-1487 Rat ABCA1 ELISA Kit (AC2898) Quantitative inquiry ASET-2014 Human APC ELISA Kit (AC3425) Quantitative inquiry ASET-2413 Mouse Has3 ELISA Kit (AC3824) Quantitative inquiry ASET-1637 Human PPAR gamma ELISA Kit (AC3048) Quantitative inquiry ASET-1578 Mouse PPAR gamma ELISA Kit (AC2989) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket